CMS Proposes Finalizing Payment Cuts for Off-Campus Hospital Clinic Visits

McGuireWoods LLP

Last year, the Centers for Medicare & Medicaid Services (CMS) implemented a controversial payment cut to certain off-campus provider-based departments (PBDs) for the most commonly billed Outpatient Prospective Payment System code — Current Procedural Terminology code G0463, “hospital outpatient clinic visit” (Code).

In its recently released calendar year 2020 proposed rule regarding the Medicare hospital Outpatient Prospective Payment System (OPPS), CMS proposes to finalize this cut after a two-year phase-in that was adopted in the calendar year 2019 final rule. This new proposal will further cut payments to certain off-campus PBDs that bill for this code by another 30 percent of the applicable on-campus rate. In addition, CMS proposes continuing certain 340B payment cuts to certain other off-campus PBDs despite legal challenges to both of these policies. On the other hand, CMS proposes to reduce the burden on physician supervision requirements for PBDs.

To assist providers in navigating these proposed rules, here are four key concepts from the proposal that could affect off-campus PBDs in 2020.

1. Clinic Visits to Receive Reduced Rates for Excepted Off-Campus PBDs

As discussed in an Aug. 28, 2018, McGuireWoods legal alert titled “CMS Proposes More Payment Cuts for Hospital Off-Campus Provider-Based Departments,” CMS sought to reduce payments for the Code because it was “not prudent for the Medicare program to pay more for these services in one setting than another.” At the time, CMS believed the Code, which represented 49 percent of all claim lines (or 30 percent of total payments) that were either separately payable or conditionally packaged services furnished by non-excepted PBDs, could be provided for less in a non-hospital setting. Accordingly, CMS proposed, and thereafter finalized, its “relativity adjuster” from the Physician Fee Schedule to the Code in excepted PBDs. Effectively, implementation of this relativity adjuster policy reduced payment to 40 percent of the applicable OPPS on-campus rate. In finalizing its relativity adjuster policy last year, CMS decided to phase it in over a two-year period. Thus, in 2019, CMS paid excepted PBDs that furnished the Code 70 percent of the applicable on-campus OPPS rate.

Now, in its proposed 2020 rule, CMS intends to finalize its phase in of the relativity adjuster policy by implementing an additional 30 percent cut of the OPPS rate. This means that the Code, if furnished by an excepted PBD, will be paid 60 percent less than it would had the code been furnished on-campus.

Given the substantial impact of the relativity adjuster policy, CMS received numerous comments against the proposal, triggering multiple lawsuits. Challengers and critics believe CMS went beyond its statutory authority in proposing the relativity adjuster policy because Congress enacted the Bipartisan Budget Act of 2015 to cut new off-campus PBDs’ payment rates and grandfathered existing PBDs (known as excepted-PBDs) to continue to receive the full OPPS rate. In response, CMS cited its authority to implement its relativity adjuster policy under Section 1833(t)(2)(F) of the Social Security Act, which requires CMS to control unnecessary increases in the volume of outpatient hospital services. As it relates to payment for the Code, CMS said it would also apply its site-neutrality reduction, notwithstanding the grandfathering of certain PBDs that occurred under the Bipartisan Budget Act.

The relativity adjuster policy was implemented in calendar year 2019 and proposed for 2020 in a non-budget neutral manner to reduce overall payments to hospitals.

2. Solicitation for Comments on 340B Drugs at Non-excepted PBDs

CMS proposes to continue paying for 340B drugs provided at non-excepted, off-campus PBDs at a lower rate under the Physician Fee Schedule in an effort to treat non-excepted PBDs in the same manner as excepted PBDs. Effectively, CMS proposes to continue paying non-excepted PBDs the average sales price minus 22.5 percent instead of the typical Physician Fee Schedule payment rate, which is equal to the average sales price plus 5 percent. This lower rate for such locations is comparable to the amounts paid to hospitals, including excepted PBDs, again furthering CMS’ site-neutrality efforts to avoid further incentives where a hospital could effectively receive the reduced 340B rate from manufacturers and continue to bill the drug at the higher Physician Fee Schedule rate.

Despite continuing its current policy, CMS is soliciting comments on the appropriate payment amount for calendar years 2018, 2019 and 2020 for the OPPS and Physician Fee Schedule, if, given the lawsuits mentioned above, courts forbid this payment policy. Notably, the U.S. District Court for the District of Columbia ruled against this policy for hospitals in December 2018, explaining that CMS’ change to hospital 340B drug payment policy was outside its statutory authority. The district court extended its ruling earlier this year to non-excepted PBDs (paid under the Physician Fee Schedule, not the hospital payment policies). CMS is appealing the district court’s rulings but seeks clarification as to whether a rate of average sales price plus 3 percent would be appropriate if courts rule against CMS on appeal. CMS has also solicited other proposals on such payments if the policy is not continued. Accordingly, providers and counsel should continue to monitor lawsuits and court rulings on these proposed rules.

3. No Further Changes to 40 Percent Relativity Adjuster for Non-excepted PBDs

Beyond those discussed above, CMS is not proposing additional changes to the 40 percent relativity adjuster for non-excepted, off-campus PBDs. As we most recently discussed in a Health Care Law Monthly article, “Recent Reimbursement-Rate Trends for Hospital Off-Campus Provider-Based Departments,” CMS implemented Section 603 of the Bipartisan Budget Act’s “site-neutral” payment policies for newly acquired, developed or relocated PBDs through a relativity adjuster. Effectively, only excepted, off-campus PBDs — such as those facilities that billed as PBDs prior to Nov. 2, 2015 — continue to be paid under the OPPS. Non-excepted PBDs, including facilities that did not bill as PBDs prior to that date, are now reimbursed under the Physician Fee Schedule, which reimburses PBDs based on a relativity adjuster to the OPPS rate, as discussed above. Currently, non-excepted PBDs receive approximately 40 percent of the OPPS rates for non-excepted items and services.

CMS has also twice proposed to limit each hospital excepted PBD to except payment only for items or services offered by the facility before Nov. 2, 2015, when the Bipartisan Budget Act passed. Effectively, any services performed in 2015 at an excepted PBD that did not fit a clinical category would also be paid 40 percent of the applicable OPPS rate under the Physician Fee Schedule. CMS has not finalized this policy, despite proposing it a second time last year.

Lastly, despite previously soliciting comments and stating that it would continue to review updated data for future rate changes, CMS has not proposed to change its relativity adjuster nor proposed a limit on new services or items outside of clinical families the facility provided in 2015 in the 2020 OPPS and Physician Fee Schedule proposed rules. Hospitals should continue to follow future rulemaking to see if CMS returns to these policies.

4. Proposed Changes in the Level of Physician Supervision in PBDs

For all hospital PBDs (including on-campus and both excepted and non-excepted locations), CMS proposes to change the required level of physician supervision for hospital outpatient therapeutic services, from “direct supervision” to “general supervision.” This reduction to the required level of physician supervision means the supervising physician need not be “immediately available to furnish assistance and direction throughout the performance of the procedure” but, instead, the service must be “under the physician’s overall direction and control.” There need not be a general requirement that a physician is present.

CMS noted that it has not received any patient complaints or other indication that lesser amounts of physician supervision had any negative impact on quality of outpatient therapeutic services, during the nearly nine years that critical access and other small hospitals have been excused from this rule. Furthermore, hospitals will need to meet higher-level supervision standards when required for specific services, and CMS specifically asked the public whether to apply this proposal to service categories like chemotherapy administration or radiation therapy. Hospitals will continue to be required to maintain an organized medical staff, have a patient under the care of a physician and maintain certain conditions of participation requirements for physician direction.

This change appears favorable in that it gives hospitals flexibility regarding requirements for physician supervision — a welcome relief for hospitals, particularly in light of some of the payment cuts discussed above — but it could have a negative impact, as well. If it continues its site-neutrality approach, CMS could, in the future, argue that PBDs do not have the same costs to justify higher payment rates. In such case, policymakers may propose additional cuts like the relativity adjuster policy described above. In the meantime, if the rule is finalized, hospitals may find this flexibility helpful to ensure patient access at their PBDs.

Bottom Line

The calendar year 2020 OPPS proposed rule continues CMS’ recent payment changes and revisions to PBD billing that will affect providers through lower site-neutral payments. CMS appears committed to furthering site-neutrality payments and reducing government spending as it relates to hospitals, which CMS Secretary Seema Verma has referenced as the Trump administration’s efforts to cut government cost. If these proposals are finalized, hospitals will receive further cuts in certain off-campus locations’ payments. On the other hand, certain physician supervision requirements may be eased. Accordingly, providers should closely examine, review and continue to monitor these proposed rules, as well as other recent rules implemented by CMS, such as its “exact match” rule, to ensure compliance in the years to come for PBDs and hospitals.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP

McGuireWoods LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide

JD Supra Privacy Policy

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook's "Like" or Twitter's "Tweet" button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network's privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals' personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at

Children's Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another's rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation ("GDPR") In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the "Your Rights" section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the "How We Share Your Data" Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at:

JD Supra Cookie Guide

As with many websites, JD Supra's website (located at (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user's login session and requires a valid username and password to obtain. It is required to access the user's profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • "Session cookies" - These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • "Persistent cookies" - These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • "Web Beacons/Pixels" - Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot - For more information about HubSpot cookies, please visit
  • New Relic - For more information on New Relic cookies, please visit
  • Google Analytics - For more information on Google Analytics cookies, visit To opt-out of being tracked by Google Analytics across all websites visit This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at:

- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.